<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00588367</url>
  </required_header>
  <id_info>
    <org_study_id>360-06</org_study_id>
    <nct_id>NCT00588367</nct_id>
  </id_info>
  <brief_title>CT Pancreas Perfusion</brief_title>
  <official_title>CT Perfusion of Pancreatic Cancer and Chronic Pancreatitis: Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. Pancreatic CT perfusion with a biofeedback breathing belt worn by the participant, and
           using novel post-processing techniques, is a reliable method which can be used to
           differentiate between pancreatic cancer, chronic pancreatitis, and autoimmune
           pancreatitis.

        2. Pancreatic CT perfusion can be used to monitor patients undergoing decompression
           treatment (endoscopic retrograde cholangiopancreatography with stent placement) for
           painful chronic pancreatitis, and the change in the pancreatic perfusion parameters
           correlate with the change in the pain parameters (pain scale and analgesic use).

        3. Pancreatic CT perfusion parameters can be calculated using surrogate scan data sets at
           specific time points to replace the continuous scanning.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2006</start_date>
  <completion_date type="Actual">February 2009</completion_date>
  <primary_completion_date type="Actual">February 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>A reproducible technique to measure CT perfusion parameters may provide a method for non-invasively monitoring tumor response during treatment, or differentiating between autoimmune and chronic pancreatitis.</measure>
    <time_frame>Three weeks to three months for chronic pancreatitis.</time_frame>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Pancreatic Ductal Adenocarcinoma</condition>
  <condition>Chronic Pancreatitis</condition>
  <condition>Autoimmune Pancreatitis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Suspected pancreatic ductal adenocarcinoma.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Chronic pancreatitis and slated for decompression treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <description>Autoimmune pancreatitis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mayo Interactive Breath Hold Monitor</intervention_name>
    <description>Biofeedback device</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Mayo Clinic patients being seen in Pancreas Clinic.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. a. Suspected pancreatic adenocarcinoma, age 35 to 99 years.

          2. a. Chronic pancreatitis with chronic pain, age 18 to 99 years. Must be a confirmed
             diagnosis by either CT, endoscopic ultrasound (EUS), or endoscopic retrograde
             cholangiopancreatography (ERCP).

        2b. To undergo endoscopic or surgical decompression with 0 to 10 days of first study visit
        CT perfusion scan.

        2c. To answer pain questionnaire before first CT perfusion scan.

        2d. To return within three weeks to three months after decompression treatment for another
        CT perfusion scan and complete the second pain questionnaire.

        3a. Autoimmune pancreatitis, age 18 to 99 years either with diffuse or focal swelling of
        the pancreas confirmed by CT, MRI, or EUS or

        3b. Irregular narrowing of the pancreatic duct on ERCP and either elevated serum
        immunoglobulin G4 (IgG4), or histological confirmation.

        Exclusion Criteria:

        1a. Pancreatic ductal adenocarcinoma tumors with vascular involvement but without vascular
        occlusion.

          1. b. Pancreatic ductal adenocarcinoma tumors less than 2 cm in size.

          2. a. Chronic pancreatitis with diffuse and extensive pancreatic calcification.

          3. a. Autoimmune pancreatitis with a prior pancreas surgery or steroid treatment for
             autoimmune pancreatitis .

        Any Cohort:

        4. Pregnant.

        5. Prior iodine contrast reactions.

        6. Iodine allergy.

        7. Decreased kidney function being a serum creatinine greater than 1.5mg/dl.

        8. Any contraindication to having a CT scan with iodine contrast.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Naoki Takahashi, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://clinicaltrials.mayo.edu</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 24, 2007</study_first_submitted>
  <study_first_submitted_qc>December 24, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 8, 2008</study_first_posted>
  <last_update_submitted>April 14, 2015</last_update_submitted>
  <last_update_submitted_qc>April 14, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 15, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Naoki Takahashi</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Inflammation</keyword>
  <keyword>Pancreas</keyword>
  <keyword>Chronic pancreatitis</keyword>
  <keyword>Alcoholic pancreatitis</keyword>
  <keyword>Carcinoma, pancreatic ductal</keyword>
  <keyword>Pancreatic neoplasms</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenocarcinoma</mesh_term>
    <mesh_term>Pancreatitis</mesh_term>
    <mesh_term>Pancreatitis, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

